Nýr örþráður kominn á markað

A HOLD Free Release 6 | eTurboNews | eTN
Skrifað af Linda Hohnholz

Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 027 micro-catheters, available in two lengths, expanding its product portfolio which includes the already FDA cleared 021 micro-catheter platform. The company expects to submit for CE Marking of both…

eTurboNews greinar eru eingöngu fyrir áskrifendur. Áskrift er FRJÁLS.
Áskrifendur skrá sig hér Smelltu hér til að gerast áskrifandi ÓKEYPIS

HVAÐ Á AÐ TAKA ÚR ÞESSARI GREIN:

  • The company expects to submit for CE Marking of both….
  • , a privately held, commercial-stage medical device company, announced today that it has received U.
  • Food and Drug Administration (FDA) 510(k) clearance for its 027 micro-catheters, available in two lengths, expanding its product portfolio which includes the already FDA cleared 021 micro-catheter platform.

<

Um höfundinn

Linda Hohnholz

Aðalritstjóri fyrir eTurboNews með aðsetur í eTN HQ.

Deildu til...